Euroespes, S.A. functions as a healthcare institution, offering a range of medical services both domestically in Spain and internationally. Its primary mission involves the investigation, identification, and therapeutic management of central nervous system disorders, as well as various other ailments. The company specializes in personalized and genomic medicine, applied for predictive insights, accurate diagnosis, and effective treatment. Additionally, it provides specific medical disciplines such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, advanced digital diagnostics, radiodiagnosis, comprehensive clinical laboratory analysis, nursing care, and cardiology services. Beyond its clinical offerings, Euroespes is dedicated to research and development across fields including biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The entity was founded in 1991 and maintains its headquarters in Corunna, Spain.